Intravenous iron as standard of care in oncology: Opportunity lost

Journal of the American Pharmacists Association

Volumn 48, Issue 4, 2008, Pages 455-457

  Auerbach, Michael ^a   Ballard, Harold ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; IRON DERIVATIVE;

ALGORITHM; ANEMIA; CHEMICALLY INDUCED DISORDER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEOPLASM; NOTE;

ALGORITHMS; ANEMIA; ANTINEOPLASTIC AGENTS; HEMATINICS; HUMANS; INFUSIONS, INTRAVENOUS; IRON COMPOUNDS; NEOPLASMS;

EID: 53049101889     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.08532     Document Type: Article

References (8)

1. Shord SS, Cuellar C. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation. J Am Pharm Assoc. 2008;48:487-493.
2. Collins A. Trend in iron testing and IV iron dosing in cancer patients receiving chemotherapy and ESA versus dialysis patients. Presented at the American Society of Hematology 45th Annual Meeting and Exposition, December 6-9, 2003, San Diego, CA.
3. Glaspy J. The development of erythropoietic agents in oncology. Expert Opin Emerg Drugs. 2005;10:553-67.
4. Zhang Y, Thamer M, Stefanik K, et al. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis. 2004;44:866-76.
5. Michel B, Coyne DW, Fishbane S, et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002;61:1830-9.
6. Coyne DW, Adkinson FN Jr, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive patients. Kidney Int. 2003;63:217-24.
7. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmen J. On the relative safety of parenteral iron formulations. Nephrol Dial Transplant. 2004;19:1571-5.
8. Rodgers GM, Auerbach M, Cella D, et al. High-molecular weight iron dextran: a wolf in sheep's clothing? J Am Soc Nephrol. 2008;19:833-4.